The FDA-approved abortion pill mifepristone is under scrutiny as the new Republican administration takes charge ...

Makary, a prominent voice on U.S. health care practices throughout his career, spent 22 years at Hopkins Medicine ...

Which bills lived or died after the Iowa Legislature's second "funnel" deadline on Friday? Check out the complete list.

Today we hear from food safety thought leaders about the impact of the FDA layoffs. MIKE TAYLOR — is board member emeritus of STOP Foodborne Illness, which supports and represents victims of ...

Health advocates sounded the alarm when President Donald Trump first nominated Robert F. Kennedy Jr. to lead the Department ...

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that Steven ...

Board member Adrejia Boutté said she believed the chiefs’ letters had triggered a law requiring the board to do so. “A district public defender who feels that he has been demoted or ...

Mick Hitchcock, Ph.D., appointed Interim Chief Executive Officer Biomea preparing icovamenib for late-stage clinical development Multiple ...

The members of the American Association for Cancer Research (AACR) have elected Keith T. Flaherty, MD, Fellow of the AACR Academy, as the AACR President-Elect for 2025-2026. Flaherty will become ...

The FDA approved mifepristone in 2000 for terminating ... said Dr. Pratima Gupta, a board member for the American College of Obstetricians and Gynecologists. “Any time a procedural abortion ...

MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics today announced the appointment of Susan Pandya, M.D., as an ...